Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Alopecia areata affects quality of life more in adolescents than adults.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Alzheimer's patients have higher levels of certain chemicals in their hair.

Low vitamin D can worsen pediatric alopecia areata.

ALUDWIG can help standardize female hair loss assessment from a single image.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

PRP is an effective and safe treatment for hair loss in women.

A 17-year-old with Netherton syndrome has dry, itchy skin, brittle hair, and high IgE levels, treated with antihistamines and emollients.

Polydopamine and quercetin together can speed up hair regrowth.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.